We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.
- Authors
Buchanan, Robert W; Davis, Miriam; Goff, Donald; Green, Michael F; Keefe, Richard S E; Leon, Andrew C; Nuechterlein, Keith H; Laughren, Thomas; Levin, Robert; Stover, Ellen; Fenton, Wayne; Marder, Steve R
- Abstract
On April 23, 2004, a joint meeting of the FDA, NIMH, MATRICS investigators, and experts from academia and the pharmaceutical industry was convened to develop guidelines for the design of clinical trials of cognitive-enhancing drugs for neurocognitive impairments in patients with schizophrenia.
- Publication
Schizophrenia bulletin, 2005, Vol 31, Issue 1, p5
- ISSN
0586-7614
- Publication type
Research
- DOI
10.1093/schbul/sbi020